Source link : https://www.newshealth.biz/health-news/anti-vegf-ocular-implant-for-age-related-macular-degeneration-to-return-to-market/
The ranibizumab ocular implant (Susvimo) for neovascular (wet) age-related macular degeneration (nAMD) will return to the U.S. market “in the coming weeks,” Genentech announced. The return follows a nearly 2-year hiatus resulting from a voluntary recall initiated after test results showed that “some implants did not perform to Genentech’s standards.” Specifically, the performance issue involved […]
Author : News Health
Publish date : 2024-07-08 21:18:02
Copyright for syndicated content belongs to the linked Source.
Categories